reference/16578574

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16578574

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	440
issn	0168-8278
issueIdentifier	4
pageRange	434-440
publicationName	Journal of Hepatology
startingPage	434
bibliographicCitation	Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Sponseller CA, Hampton K, Bacon BR. Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol. 2003 Apr;38(4):434–40. doi: 10.1016/s0168-8278(03)00027-8. PMID: 12663234.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbdc83c722407d73f070a58cbf4e11e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3f9e500358a7f8a7b01ea0ddb5ac963 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eef4b24736e1135fbf52b18b3a5d0e93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15550290313aa6feca9f88c27221705a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_812e93411836a273a52a80bb9c6d694e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8df5c822e2738fd11cb0879406121ccd
date	200304
identifier	https://doi.org/10.1016/s0168-8278%2803%2900027-8 https://pubmed.ncbi.nlm.nih.gov/12663234
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4786 https://portal.issn.org/resource/ISSN/0168-8278
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
discusses	http://id.nlm.nih.gov/mesh/M0001823 http://id.nlm.nih.gov/mesh/M0237199 http://id.nlm.nih.gov/mesh/M0012508 http://id.nlm.nih.gov/mesh/M0000620 http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0447306 http://id.nlm.nih.gov/mesh/M0027373 http://id.nlm.nih.gov/mesh/M0010903
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014157Q000378 http://id.nlm.nih.gov/mesh/D007333 http://id.nlm.nih.gov/mesh/D005234Q000188 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D018160Q000378 http://id.nlm.nih.gov/mesh/D045162Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001835Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005951 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000077154 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010865 http://id.nlm.nih.gov/mesh/D001219Q000097 http://id.nlm.nih.gov/mesh/D010352 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005234Q000378 http://id.nlm.nih.gov/mesh/D008024 http://id.nlm.nih.gov/mesh/D000410Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7987 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8075 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fd4f4a57669e0f4c45eb5cc883ad7e4e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127863084

Total number of triples: 70.